Christopher Jessop

Christopher Ian Jessop’s maneuvers to suppress critical information about his ventures are particularly audacious. This report aims to illuminate the red flags associated with Jessop and his affiliated entities, highlighting his attempts to censor unfavorable media coverage. Potential investors and regulatory authorities, consider yourselves warned.​

A Web of Directorships: A Closer Look

Jessop’s portfolio boasts positions in various companies, including ABL789 Holdings Ltd., CBTC UK Holdco Ltd., and Quality Pet Care Ltd. While an impressive lineup on paper, a deeper dive reveals a pattern of opaque operations and questionable practices.​

ABL789 Holdings Ltd.: This healthcare company, under Jessop’s directorship since March 2020, offers services like cancer prehabilitation and diabetes management programs. However, specifics about their operational efficacy and patient outcomes remain elusive, raising concerns about transparency. ​

CBTC UK Holdco Ltd.: An investment holding company established in 2019, with Jessop on board since February 2021. The firm’s vague description and lack of clear investment portfolios make one question the legitimacy and intent behind its operations. ​

Quality Pet Care Ltd.: Managing veterinary clinics and pet healthcare plans sounds noble. Yet, under Jessop’s directorship since March 2019, there is scant information on the quality of care provided, leaving pet owners in the dark. ​

The Art of Censorship: Silencing Dissent

Jessop’s tactics to muzzle unfavorable press are reminiscent of broader, more sinister global censorship trends. By attempting to erase critical narratives, he not only undermines the public’s right to information but also mirrors the actions of authoritarian regimes that prioritize image over integrity.​

Investor Caution: The Writing on the Wall

For those contemplating investments in Jessop’s ventures, the signs couldn’t be clearer:

Opaque Operations: A consistent lack of transparency across his business endeavors.​

Censorship Tactics: Active efforts to suppress critical media, indicating potential underlying issues.​

Regulatory Scrutiny: The possibility of increased attention from authorities due to questionable practices.​

Conclusion: 

Christopher Ian Jessop’s pattern of obfuscation and censorship is not just a red flag—it’s a glaring siren. Investors should exercise extreme caution, and regulatory bodies must delve deeper into his operations. In a world where transparency is paramount, Jessop’s actions serve as a stark reminder of the lengths some will go to shield the truth